BioCity Biopharma ("BioCity") announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to ...

The aldosterone-renin screening market is forecasted to grow from USD 574.8 million in 2025 to USD 1,109.7 million by 2035, at a CAGR of 6.8% during the forecast period. The aldosterone-renin ...

While heart disease has been the leading cause of death in the U.S. for over a century, the past 50 years have seen a ...

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...

First- and second-generation potassium binders reduced potassium levels in a Swedish cohort of patients, despite premature ...

"Further research on choosing antihypertensive medications based on baseline aldosterone-to-renin ratio or plasma renin activity may enhance treatment success in resistant hypertension." ...

Low renin and high aldosterone may mean your adrenal glands aren’t working the way they should. If both are high, it can be a sign that there’s a problem with your kidneys.

Assessing concentrations of aldosterone and renin is beneficial in determining if the adrenal insufficiency is primary rather than secondary or tertiary. In AD, ...

Key messages - The available evidence from short-term studies suggests there is probably little to no difference between renin inhibitors and angiotensin receptor blockers in terms of death rates, ...

Physiology of the Renin-Angiotensin-Aldosterone System and Its Pathophysiologic Role in Some Forms of Hypertension. An extensive literature regarding this system is available, and its detailed ...

The renin-angiotensin-aldosterone system (RAAS) in your body helps control your blood pressure and blood volume. It includes renin (an enzyme), and the hormones angiotensin II and aldosterone.